← All trials
NCT06292208
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 2, 2024
- Primary completion
- Dec 31, 2029
- Completion date
- Dec 31, 2030
- First posted
- Mar 5, 2024
- Last posted
- Mar 5, 2024
- Enrollment
- 48
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- SUNHO（China）BioPharmaceutical CO., Ltd.Lead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.